News Detail
London, 8 July 2023: A cancer patient died and four others spent time in hospital after a pharmaceutical company gave them "unlicensed" chemotherapy medicine.
The health watchdog has now launched a probe as Sciensus, which provides treatment to around 200,000 in the UK......
View Details
Source : Mirror UK
cancer patient
cancer patient died
pharmaceutical company
"unlicensed" chemotherapy medicine
Sciensus
cabazitaxel
Related News
- The coming booster for Indian pharma stocks: US Biosecure Act (10-09-2024)
- Telangana DCA officials seized 635 bottles of Glycoril cough syrup, along with printed labels (10-09-2024)
- GST reduced on Cancer life-saving drugs from 12% to 5% (10-09-2024)
- Penicillin G & Clavulanic acid Plant to start production soon: DoP (10-09-2024)
- Use latest tech to develop Green Pharma City: CM Revanth Reddy to officials (10-09-2024)
- FSSAI issues draft to include natamycin as preservative in additives norms (10-09-2024)
- Domestic formulations biz expected to grow 9-10% over next decade: Glenmark (09-09-2024)
- Biological drugs don't harm, but fix immunity: Experts (09-09-2024)
- Mumbai: Anti-Narcotics Cell Seizes 300 Codeine-Based Cough Syrup Bottles in Dharavi area (08-09-2024)
- Police seize 100 bottles of Eskuf cough syrup at Agartala railway station (08-09-2024)